doc. MUDr. Igor Kiss, Ph.D., MBA
Department head, Comprehensive Cancer Care Department
Total number of publications: 247
2022
-
Use of Hypolipidemic Drugs and the Risk of Second Primary Malignancy in Colorectal Cancer Patients
Cancers, year: 2022, volume: 14, edition: 7, DOI
-
Volumetric Analysis of Hepatocellular Carcinoma After Transarterial Chemoembolization and its Impact on Overall Survival.
In vivo, year: 2022, volume: 36, edition: 5, DOI
2021
-
Administration of Nivolumab in Metastatic Renal Cell Cancer Following Treatment With mTOR Inhibitors
In vivo, year: 2021, volume: 35, edition: 5, DOI
-
An Independent Validation Study of Candidate microRNAs as Predictive Biomarkers for Bevacizumab-based Therapy in Patients With Metastatic Colorectal Cancer
In vivo, year: 2021, volume: 35, edition: 5, DOI
-
CoVigi phase IV multicentric trial evaluating COVID-19 vaccination adverse events and immune response dynamics in cancer patients: First results on antibody and cellular immunity
Year: 2021, type: Conference abstract
-
Drug interaction profile of TKI alectinib allows effective and safe treatment of ALK plus lung cancer in the kidney transplant recipient
International Immunopharmacology, year: 2021, volume: 99, edition: October 2021, DOI
-
Klinická onkologie pro mediky. Solidní nádory, nádory dětského věku a hematologické malignity
Year: 2021, type:
-
Klinická pankreatologie
Year: 2021, number of pages: 432 s.
-
Nádory pankreatu
Klinická pankreatologie, year: 2021
-
Nutriční péče v onkologii, Žilní přístupy a komplikace periferních a centrálních kanyl a portů a léčba těchto komplikací
Klinická onkologie pro mediky, year: 2021